Apixaban reduces clot risk in dialysis patients after vascular procedure: Study

A recent study from National Taiwan University Hospital shows that apixaban, a blood-thinning medication, can help prevent blood clots in dialysis patients after a procedure to clear blocked vascular access. Dialysis patients rely on vascular access—like fistulas or grafts—to filter their blood, but clots can form and block these pathways, making dialysis impossible.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup